HMG-CoA reductase inhibitors: assessing differences in drug interactions and safety profiles.

Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)

Volumn 40, Issue 5, 2000, Pages 637-644

  Beaird, S L ^a  

^a HealthTech Solutions   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; CYTOCHROME P450; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

DRUG INTERACTION; HUMAN; METABOLISM; REVIEW;

CHOLINESTERASE INHIBITORS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 0034266349     PISSN: 10865802     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1086-5802(16)31104-4     Document Type: Article

References (52)